Differing from cholesterol in the absence of the double bond.
References in periodicals archive ?
2) It is caused by mutations in the CYP27A1 gene, which lead to deficiency of the mitochondrial enzyme, sterol 27-hydroxylase, resulting in the accumulation of cholestanol in the serum and many affected tissues (3) CTX manifests as tendon xanthomas, juvenile cataracts and seizures multiple progressive neurological symptoms.
6) The major symptoms are produced by accumulation of cholestanol and cholesterol, particularly in the nervous system, atherosclerotic plaques, and bone and tendon xanthomas (7) Classic clinical features resemble progressive cerebellar ataxia associated with premature juvenile-onset cataracts and intractable chronic diarrhea, jaundice in infancy, and later, with tendon xanthomas (prominently in the Achilles tendon, in tibial tuberosity, in the triceps brachialis, and in the extensor tendons of the fingers), osteoporosis, and myocardial infarction Tendon xanthomas typically develop after the second decade.
Laboratory studies show elevated plasma cholestanol levels in gas chromatography or HPLC-a hallmark of the disease, with normal or decreased cholesterol levels.
Cholesterol has been shown to biologically hydrogenate into coprostanol and cholestanol (dihydrocholesterol) in anoxic sediments, and the conversion to coprostanol has been shown to be negligible.
Since coprostanol is thought to originate from fecal sources, and cholesterol and cholestanol represent sewage and nonsewage sources, this ratio may be used as a more specific and simplified indicator of sewage contamination.
However, her cholestanol level at 4 mg/dL was elevated to about 30 times normal.
It is an interesting disease, with the diagnosis made by measuring plasma and urine cholestanol," he said.
It shows an abnormally high concentration of the diagnostic metabolite cholestanol (C-18 [H.
First, the relative peak area compared with cholestanol was very similar in the gas chromatogram and the 1-dimensional [sup.
Such patients can be readily identified by measuring serum cholestanol concentrations before beginning statin therapy according to Dr.
Miettinen and associates analyzed the data on serum noncholesterol sterols, including cholestanol (BMJ 316[7138]:1127-30, 1998).